Tag archive for ‘Curetech’
Koby Yeshayahou On Sunday, December 21st, 2014

Medivation takes up $335 million Curetech licensing option

– The agreement gives Medivation the license to develop and commercialize Curetech’s pidilizumab cancer treatment. –   Medivation has decided to exercise the option granted it by Curetech More...

Wordpress site Developed by Fixing WordPress Problems